Nicole Kucine, MD, MS, Weill Cornell Medicine, New York, NY, speaks on the latest developments in pegylated interferon use for the treatment of polycythemia vera and essential thrombocythemia in pediatric and adolescent and young adult (AYA) patients. Dr Kucine talks on outcomes with pegylated interferon and provides an update on the efficacy and safety profile, talking specifically about individual cases in response to this therapy. This interview took place at the Texas MPN Workshop: Second Annual Workshop and Meeting in 2021.
